Skip to main content

EDITORIAL article

Front. Endocrinol.
Sec. Cardiovascular Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1471571
This article is part of the Research Topic Molecular biomarkers of cardiometabolic disease View all 10 articles

Editorial on the Research Topic "Molecular biomarkers of cardiometabolic disease"

Provisionally accepted
Mirjana T. Macvanin Mirjana T. Macvanin 1*Aleksandra Klisic Aleksandra Klisic 2Esma R. Isenovic Esma R. Isenovic 3
  • 1 Independent Researcher, Belgrade, Serbia
  • 2 Primary Health Care Center Podgorica, Podgorica, Montenegro
  • 3 Laboratory for Radiobiology and Molecular Genetics, Vinča Institute of Nuclear Science, University of Belgrade, Belgrade, Serbia

The final, formatted version of the article will be published soon.

    Keywords: biomarker, cardiometabolic disease, type 2 diabetes, cardiovascular disease, Risk Assessment, Diagnostic biomarker, micro RNA, machine learning

    Received: 27 Jul 2024; Accepted: 30 Jul 2024.

    Copyright: © 2024 Macvanin, Klisic and Isenovic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mirjana T. Macvanin, Independent Researcher, Belgrade, Serbia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.